Art

J-GLOBAL ID：200902286800981088   Reference number：05A0423527

Aberrant methylations in cancer cells: Where do they come from?

癌細胞におけるメチル化異常 この異常は何処からやってくるのか?

Author (2)： USHIJIMA Toshikazu (National Cancer Center Res. Inst., Tokyo, JPN) ,  OKOCHI-TAKADA Eriko (National Cancer Center Res. Inst., Tokyo, JPN)
Material： Cancer Science  (Cancer Sci)
Volume： 96  Issue： 4  Page： 206-211  Publication year： Apr. 2005 
JST Material Number： W1423A  ISSN： 1347-9032  Document type： Article
Article type： 文献レビュー  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *neuroblastoma

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0423527&from=J-GLOBAL&jstjournalNo=W1423A") }}

JST classification (1)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (78)：

• JONES, PA. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002, 3, 415-428
• OHTANI-FUJITA, N. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene. 1993, 8, 1063-1067
• FEINBERG, AP. The history of cancer epigenetics. Nat Rev Cancer. 2004, 4, 143-153
• HERMAN, JG. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 1994, 91, 9700-9704
• GONZALEZ-ZULUETA, M. Methylation of the 5'-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995, 55, 4531-4535

Terms in the title (2)： 癌細胞 ,  メチル化